CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
BELASTUNGSFRAGEBOGEN PARKINSON KURZVERSION (BELA-P-K)other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03073044
NCT03073044N/ACompleted
CompareCT.gov

Italian Validation of the Belastungfragebogen Parkinson Kurzversion (BELA-P-K): a Disease-specific Questionnaire for Evaluation of the Subjective Perception of Quality of Life.

Ospedale Generale Di Zona Moriggia-Pelascini·observational·Posted Mar 8, 2017·Updated Mar 8, 2017

In Brief

An observational study evaluating BELASTUNGSFRAGEBOGEN PARKINSON KURZVERSION (BELA-P-K) for Parkinson Disease. Completed, enrolled 100 participants.

Detailed Summary

The BELA-P-k was translated from Dutch into Italian. Subsequently 102 patients with PD filled out the questionnaire

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsParkinson Disease
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMar 8, 2017
Enrollment StartSep 1, 2015
Primary CompletionSep 1, 2016
Study CompletionFeb 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 9.3 years ago

Interventions

BELASTUNGSFRAGEBOGEN PARKINSON KURZVERSION (BELA-P-K)other

we proposed the translation and validation of Bela-p-K, a questionnaire that evaluates the Quality of Life in parkinsonian patients. we applied the method of translation and back-translation at dutch version of questionnaire. after, we evaluated 103 PD patients with Bela-p-K and PDQ39. The internal consistency of questionnaire was analyzed calculating alpha-Chronbach. We also evaluated the construct validity correlating Bela-p-K and PDQ39